GlassScriptPhysician profile
Joseph William Phillips
NPI 1306269741
$444.87
in general payments reported to CMS, 2019-2025
10 companies · $49.27 in 2025
The $49.27 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.04 · 2022: $200 · 2023: $134 · 2024: $29.36 · 2025: $49.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $127.15 | 2022 | |
| Sun Pharmaceutical Industries INC. | $113.30 | 2023 | |
| Theratechnologies INC. | $41.20 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $35.59 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $34.86 | 2025 | |
| Merck Sharp & Dohme LLC | $30.51 | 2021-2025 | Pifeltro, Capvaxive |
| Shionogi INC | $20.21 | 2023 | Fetroja |
| Biomerieux INC | $15.86 | 2024 | Filmarray Bcid2 Control Panel M416 |
| Viiv Healthcare Company | $13.50 | 2024 | Apretude |
| Janssen Biotech, INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.